Welcome to our dedicated page for Amdocs SEC filings (Ticker: DOX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Amdocs Limited (NASDAQ: DOX) SEC filings page provides access to the company’s regulatory disclosures as a foreign private issuer. Amdocs files annual reports on Form 20-F, which include consolidated financial statements, an operating and financial review, and detailed information on its business as a provider of software and services to communications, entertainment, and media service providers. The company also furnishes Form 6-K current reports containing quarterly financial information, earnings press releases, presentations, and proxy materials.
In its filings, Amdocs presents data on revenue, operating income, net income, earnings per share, free cash flow, and backlog, and explains the impact of phasing out certain low-margin, non-core business activities. The company uses both GAAP and non-GAAP financial measures and provides reconciliations, as shown in its Form 6-K for the quarter ended June 30, 2025 and in its fiscal 2025 earnings release furnished as an exhibit to a Form 6-K. These documents also discuss managed services revenue, cloud-related activities, and guidance ranges for future periods.
Amdocs’ SEC submissions include notices and proxy statements related to its annual general meeting of shareholders. In a Form 6-K, the company furnishes a notice of annual general meeting that outlines proposals such as the election of directors, amendments to the employee share purchase plan, approval of an increase in the dividend rate under its quarterly cash dividend program, approval of consolidated financial statements, and ratification of the independent registered public accounting firm. The proxy materials describe voting procedures, quorum requirements, and the use of notice-and-access for distributing proxy information.
Through this page, users can review Amdocs’ Form 20-F annual report for the year ended September 30, 2025, which is furnished as an exhibit to a Form 6-K, along with other Form 6-K reports that incorporate unaudited consolidated financial statements and earnings presentations. AI-powered summaries can help explain key sections of lengthy filings, highlight trends in revenue and profitability, and clarify the structure of Amdocs’ business and capital allocation policies. This makes it easier to interpret the company’s financial disclosures, governance proposals, and other regulatory information contained in its SEC filings.
Amdocs Limited reported a leadership transition in its management and board. In connection with his retirement from Amdocs’ management team, Shuky Sheffer has also retired from the Board of Directors. The Board has appointed Shimie Hortig as a new director, effective concurrently with his replacement of Mr. Sheffer as President and Chief Executive Officer of Amdocs Management Limited.
The company describes itself as a leading provider of software and services to communications and media companies and reported revenue of $4.53 billion in fiscal 2025. The press release also reiterates standard forward-looking statement language, highlighting risks related to macroeconomic conditions, competition, technology shifts, security incidents and customer spending.
Amdocs Ltd director Sarah R. Davis has filed an initial ownership report showing her current equity stake in the company. The Form 3 discloses direct ownership of 16,488 Ordinary Shares, which include Ordinary Shares underlying outstanding restricted stock units. This filing records her starting position as a director rather than any new share purchase or sale.
DOX filed a Form 144 notifying a proposed sale of Ordinary shares tied to previously issued Restricted Stock Units. The filing lists multiple award dates and grant sizes, including 41,434 (11/13/2018), 30,895 (11/15/2019), and 18,724 (11/15/2019).
The notice identifies Oppenheimer & Co. Inc. as the broker and references 03/18/2026 and Nasdaq as the market; the filing lists several additional RSU grant counts by grant date.
Amdocs Ltd director Yvette Kanouff filed an initial insider ownership report showing beneficial ownership of 24,200 Ordinary Shares of the company. These holdings are reported as being owned directly and include Ordinary Shares subject to outstanding restricted stock awards. The filing does not report any recent buy or sell transactions, only the current equity position.
Amdocs Ltd officer Rapaport-Dagim Tamar filed an initial ownership report showing 294,517 Ordinary Shares held directly. This total includes Ordinary Shares that are subject to outstanding restricted stock awards, reflecting both vested and unvested equity-based compensation, with no new buy or sell transaction reported.
Amdocs Ltd director Rafael De La Vega has filed an initial ownership report showing his equity stake in the company. The Form 3 states that he directly holds 29,836 Ordinary Shares, and a footnote explains this number includes Ordinary Shares subject to outstanding restricted stock awards. The filing does not report any recent share purchases or sales; it simply establishes his current holdings as a company director.
Amdocs Ltd director Adrian Gardner has reported his share ownership in the company. He holds 33,522 Ordinary Shares directly and an additional 20,000 Ordinary Shares indirectly through his spouse. The reported amounts include Ordinary Shares that are subject to outstanding restricted stock awards.
AMDOCS LTD director Genish Amos filed an initial ownership report showing his equity position in the company. The filing reports direct ownership of 11,353 Ordinary Shares, including shares subject to outstanding restricted stock units. This Form 3 does not disclose any buy or sell transactions; it simply establishes his current holdings.
Amdocs Ltd director Gelman Eliahu Meir filed an initial ownership report showing a substantial equity stake in the company. The Form 3 lists direct beneficial ownership of 340,136 Ordinary Shares. A footnote explains that this figure includes Ordinary Shares subject to outstanding restricted stock awards, so the total reflects both vested and unvested equity-based compensation rather than a recent market transaction.
Amdocs Ltd director Veronique Morali reported her initial holdings of company equity in a Form 3. The filing shows she beneficially owns 4,405 Ordinary Shares, which are represented by shares of Class A Common Stock subject to outstanding restricted stock units. This reflects her existing equity-based compensation position rather than a new market transaction.